Novel spliced form of a lens protein as a novel lung cancer antigen, Lengsin splicing variant 4

Cancer Science

Volumn 100, Issue 8, 2009, Pages 1485-1493

  Nakatsugawa, Munehide ^a   Hirohashi, Yoshihiko ^a   Torigoe, Toshihiko ^a   Asanuma, Hiroko ^a   Takahashi, Akari ^b   Inoda, Satoko ^a   Kiriyama, Kenji ^a   Nakazawa, Emiri ^b   Harada, Kenji ^c   Takasu, Hideo ^c   Tamura, Yasuaki ^a   Kamiguchi, Kenjiro ^a   Shijubo, Noriharu ^a,d   Honda, Ryoichi ^e   Nomura, Naohiro ^f   Hasegawa, Tadashi ^a   Takahashi, Hiroki ^a   Sato, Noriyuki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^d Sapporo General Hospital of Hokkaido Railway Company   (Japan)

^e Sapporo Tokushukai Hospital   (Japan)

^f Kitahiroshima Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LENGSIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FEMALE; FETUS; GENE LOCATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGENICITY; LUNG CANCER; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; RNA SPLICING;

ADENOCARCINOMA; AGED; ANTIGENS, NEOPLASM; CARCINOMA, LARGE CELL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL LINE, TUMOR; EYE PROTEINS; FEMALE; GLUTAMATE-AMMONIA LIGASE; HUMANS; IMMUNOHISTOCHEMISTRY; LENS, CRYSTALLINE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROTEIN ISOFORMS; PROTEIN SPLICING; RNA, MESSENGER; RNA, SMALL INTERFERING; SMALL CELL LUNG CARCINOMA; TRANSFECTION;

EID: 67650663995     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01187.x     Document Type: Article

References (28)

1. American Cancer Society. Cancer Facts and Figures. Atlanta, GA: American Cancer Society, 2007.
2. Brunsvig PF, Aamdal S, Gjertsen MK et al. Telomerase peptide vaccination: A phase I/II study in patients with non-small cell lung cancer. Cancer Immunol Immunother 2006; 55: 1553-64.
3. Oka Y, Tsuboi A, Taguchi T et al. Induction of WT1 (Wilms'tumor gene) - specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression. Proc Natl Acad Sci USA 2004; 101: 13 885-90.
4. Golub TR, Slonim DK, Tamayo P et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286: 531-7.
5. Grassi F, Moretto N, Rivetti C et al. Structural and functional properties of lengsin, a pseudo-glutamine synthetase in the transparent human lens. Biochem Biophys Res Commun 2006; 350: 424-9.
6. Wyatt K, White HE, Wang L et al. Lengsin is a survivor of an ancient family of class I glutamine synthetases re-engineered by evolution for a role in the vertebrate lens. Structure 2006; 14: 1823-34.
7. Wyatt K, Gao C, Tsai JY et al. A role for lengsin, a recruited enzyme, in terminal differentiation in the vertebrate lens. J Biol Chem 2008; 283: 6607-15.
8. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111: 1710-7.
9. Hirohashi Y, Torigoe T, Maeda A et al. An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin. Clin Cancer Res 2002; 8: 1731-9.
10. Hariu H, Hirohashi Y, Torigoe T et al. Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancer. Clin Cancer Res 2005; 11: 1000-9.
11. Sato E, Torigoe T, Hirohashi Y et al. Identification of an immunogenic CTL epitope of HIFPH3 for immunotherapy of renal cell carcinoma. Clin Cancer Res 2008; 14: 6916-23.
12. Yagihashi A, Asanuma K, Nakamura M et al. Detection of anti-survivin antibody in gastrointestinal cancer patients. Clin Chem 2001; 47: 1729-31.
13. Wistow G, Bernstein SL, Wyatt MK et al. Expressed sequence tag analysis of adult human lens for the NEIBank project: Over 2000 non-redundant transcripts, novel genes and splice variants. Mol Vis 2002; 8: 171-84.
14. Streilein JW. Ocular immune privilege: Therapeutic opportunities from an experiment of nature. Nat Rev Immunol 2003; 3: 879-89.
15. Martin WD, Egan RM, Stevens JL, Woodward JG. Lens-specific expression of a major histocompatibility complex class I molecule disrupts normal lens development and induces cataracts in transgenic mice. Invest Ophthalmol Vis Sci 1995; 36: 1144-54.
16. Polans AS, Witkowska D, Haley TL et al. Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy. Proc Natl Acad Sci USA 1995; 92: 9176-80.
17. Maeda A, Ohguro H, Maeda T et al. Aberrant expression of photoreceptor-specific calcium-binding protein (recoverin) in cancer cell lines. Cancer Res 2000; 60: 1914-20.
18. Adamus G, Machnicki M, Seigel GM. Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy. Invest Ophthalmol Vis Sci 1997; 38: 283-91.
19. Maeda T, Maeda A, Maruyama I et al. Mechanisms of photoreceptor cell death in cancer-associated retinopathy. Invest Ophthalmol Vis Sci 2001; 42: 705-12.
20. Maeda A, Maeda T, Ohguro H, Palczewski K, Sato N. Vaccination with recoverin, a cancer-associated retinopathy antigen, induces autoimmune retinal dysfunction and tumor cell regression in mice. Eur J Immunol 2002; 32: 2300-7.
21. Fijak M, Meinhardt A. The testis in immune privilege. Immunol Rev 2006; 213: 66-81.
22. Uyttenhove C, Godfraind C, Lethe B et al. The expression of mouse gene P1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigen. Int J Cancer 1997; 70: 349-56.
23. van der Bruggen P, Traversari C, Chomez P et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991; 254: 1643-7.
24. Chen YT, Scanlan MJ, Sahin U et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 1997; 94: 1914-8.
25. Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT. Cancer/testis antigens: An expanding family of targets for cancer immunotherapy. Immunol Rev 2002; 188: 22-32.
26. Jager D, Unkelbach M, Frei C et al. Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum. Cancer Immun 2002; 2: 5.
27. Monji M, Senju S, Nakatsura T et al. Head and neck cancer antigens recognized by the humoral immune system. Biochem Biophys Res Commun 2002; 294: 734-41.
28. Okada T, Akada M, Fujita T et al. A novel cancer testis antigen that is frequently expressed in pancreatic, lung, and endometrial cancers. Clin Cancer Res 2006; 12: 191-7.